She warned a costly project was failing - then says HR was drawn into her exit
A former AstraZeneca executive says the drugmaker's own HR team helped push her out after she reported concerns at work.
The former vice president, who worked in AstraZeneca's BioPharmaceutical Development group, sued the company in Maryland federal court on August 4, 2026, alleging retaliation, sex discrimination, and unpaid wages. According to the complaint, she led a global team of about 170 scientists and engineers from 2022 until she was terminated on February 26, 2025.
Her lawsuit describes two sets of concerns that, she alleges, overlapped. In one, she says she warned that a costly new manufacturing process was not working, and that the project's leaders were "misrepresenting the data" to senior management as the company weighed spending hundreds of millions of dollars on a new Maryland plant. In the other, she says she reported that a senior male scientist was mistreating women and took part in a Human Resources investigation into those complaints.
For HR professionals, the timeline is central to the claim. The former executive alleges she raised her concerns about the manufacturing process at an October 2024 meeting. Days later, according to the filing, her supervisor accused her of being unprofessional at that meeting - an accusation she says was false - and began asking her colleagues about her conduct, something she describes as "a fishing expedition to dig up dirt."
Human Resources then entered the picture, the complaint alleges. It says her supervisor convened a January 2025 meeting with HR and claimed employees had complained about her. The former executive says those complaints were "false and pretext for discrimination," noting that one cited incident was her conduct at the same October meeting where she had raised her concerns. She was terminated weeks later, the filing says, shortly after HR issued its report on the mistreatment complaints.
The complaint also alleges inconsistent treatment. It says the senior male scientist accused of mistreating women kept his position and continued supervising women who had complained, while the plaintiff was abruptly terminated over what she describes as far less serious conduct. Among the stated reasons for her firing, according to the filing, were criticisms she calls sex-stereotyped: an "aggressive tone" and words "considered intimidating." Men, she alleges, were not disciplined the same way.
According to the complaint, the former executive brings claims under the Sarbanes-Oxley Act, which protects certain corporate whistleblowers; the anti-retaliation provision of the Maryland False Claims Act; Title VII of the Civil Rights Act of 1964; the Maryland Human Relations Act; the Montgomery County Human Rights Act; and the Maryland Wage Payment and Collection Law. The wage claim centers on a 2024 bonus she says she had already earned but was not fully paid.
The complaint states that she filed a charge with the Equal Employment Opportunity Commission, which issued a Notice of Right to File Suit on May 6, 2026, and that she filed a complaint with OSHA on August 25, 2025.
The allegations have not been tested in court, and no judge has ruled.
